IP Library › Granted Patent US 12,578,786
Granted Patent B1
US 12,578,786 · App. 19/210,730 · Granted Mar 17, 2026

Customizing virtual and augmented reality experiences for neurodevelopmental therapies and education

Inventors: Vijay Ravindran (Washington, DC); Ali Moeeny (Baltimore, MD); Sarah Bhandiwad (Bethesda, MD)
G06F3/011G06T19/006G09B5/06G16H20/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,578,786
App. No.
19/210,730
Granted
Mar 17, 2026
Kind
B1
Abstract

Provided are platforms, methods, and systems to customize virtual or augmented reality (collectively, XR) content for an individual or a group of individuals, such as to treat a user having a mental or neurodevelopmental disorder (e.g., autism), train or educate an individual (e.g., student) or a group of individuals, or otherwise attend to a special need of an individual or a group of individuals. A graphical user interface may be used to edit the XR content.

Claims (33)

1 . A system for treating or supplementing the treatment of a subject with one or more mental or developmental conditions, comprising: a processor of a computing device; and a non-transitory medium with instructions stored thereon that, when executed by the processor, direct the computing device to perform operations comprising:

a. generating a subject profile, wherein the subject profile is based at least in part on one or more characteristics of the subject;

b. assigning one or more therapeutic goals to the subject, wherein the one or more therapeutic goals are based at least in part on the subject profile; and

c. presenting a virtual world to the subject using a virtual or augmented reality device that provides visual, auditory, or haptic stimulation, wherein the virtual world comprises interactive content configured to aid the subject in progressing towards the one or more therapeutic goals.

2 . The system of claim 1 , wherein the one or more therapeutic goals are related to a symptom of the one or more mental or developmental conditions of the subject.

3 . The system of claim 2 , wherein the one or more mental or developmental conditions comprise autism.

4 . The system of claim 2 , wherein the one or more mental or developmental conditions comprise ADHD.

5 . The system of claim 1 , wherein the one or more characteristics of the subject comprise one or more cognitive or perceptual conditions.

6 . The method of claim 5 , wherein the one or more cognitive or perceptual conditions comprise one or more phobias.

7 . The method of claim 5 , wherein the one or more cognitive or perceptual conditions comprise one or more dysmorphias.

8 . The system of claim 1 , wherein the one or more characteristics of the subject comprise the gender of the subject.

9 . The system of claim 1 , wherein the one or more characteristics of the subject comprise the educational level of the subject.

10 . The system of claim 1 , wherein the one or more characteristics of the subject comprise the exposure level of the subject to XR therapies.

11 . The system of claim 1 , wherein the one or more characteristics of the subject comprise the age of the subject.

12 . The system of claim 1 , wherein generating the subject profile comprises selecting a pre-existing profile from a library of profiles.

13 . The system of claim 1 , wherein the virtual world presented to the subject comprises a selection from a pre-existing library of virtual worlds.

14 . The system of claim 13 , wherein the selection is based at least in part on the subject profile.

15 . The system of claim 14 , wherein the virtual world is generated based at least in part on the subject profile.

16 . The system of claim 13 , wherein the selection is based at least in part on the one or more therapeutic goals.

17 . The system of claim 1 , wherein the virtual world presented to the subject is first generated by the system.

18 . The system of claim 1 , wherein the one or more therapeutic goals comprise learning or training a certain social skill, increasing concentration ability, training processing speed, facilitation communication, reducing anxiety, promoting self-esteem, learning functional skills, or managing sensory overload, or any combination thereof.

19 . The system of claim 1 , wherein generating the subject profile further comprises comparing the one or more characteristics of the subject with a database.

20 . The system of claim 1 , wherein the interactive content is configured to aid in learning or training a social skill.

21 . A system for treating or supplementing the treatment of a subject with one or more mental or developmental conditions, comprising: a processor of a computing device; and a non-transitory medium with instructions stored thereon that, when executed by the processor, direct the computing device to perform operations comprising:

a. presenting a subject with a virtual world using a virtual or augmented reality device that provides visual, auditory, or haptic stimulation, wherein the virtual world comprises interactive content configured to aid the subject in progressing towards one or more therapeutic goals;

b. measuring the subject's progress towards the one or more therapeutic goals;

c. generating a subject profile, wherein the profile is based on the progress of the subject towards one or more therapeutic goals; and

d. modifying the virtual world based at least in part on the subject profile.

22 . The system of claim 21 , wherein the one or more therapeutic goals are related to a symptom of the one or more mental or developmental conditions of the subject.

23 . The system of claim 22 , wherein the one or more mental or developmental conditions comprise autism.

24 . The system of claim 22 , wherein the one or more mental or developmental conditions comprise ADHD.

25 . The system of claim 22 , wherein the one or more therapeutic goals comprise learning or training a certain social skill, increasing concentration ability, training processing speed, facilitation communication, reducing anxiety, promoting self-esteem, learning functional skills, or managing sensory overload, or any combination thereof.

26 . The system of claim 21 , wherein the interactive content is configured to aid in learning or training a social skill.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2025
From: RAVINDRAN, VIJAY; MOEENY, ALI; BHANDIWAD, SARAH
To: FLOREO, INC.
Reel/Frame 073188/0426 →
Continuity (3)
Continuation 18795031 · Aug 5, 2024
Continuation 16594248 · Oct 7, 2019
Provisional Application 62742648 · Oct 8, 2018
References Cited (259)
US 5727950A · Cook et al. · 1998 [cited by applicant]
US 5754738A · Saucedo et al. · 1998 [cited by applicant]
US 5879163A · Brown et al. · 1999 [cited by applicant]
US 6162189A · Girone et al. · 2000 [cited by applicant]
US 6496208B1 · Bernhardt et al. · 2002 [cited by applicant]
US 6611242B1 · Hongo et al. · 2003 [cited by applicant]
US 7650349B2 · Yeh et al. · 2010 [cited by applicant]
US 8503720B2 · Shotton et al. · 2013 [cited by applicant]
US 8682756B1 · Tifford et al. · 2014 [cited by applicant]
US 8934026B2 · Tian et al. · 2015 [cited by applicant]
US 9262673B2 · Shotton et al. · 2016 [cited by applicant]
US 9354709B1 · Heller et al. · 2016 [cited by applicant]
US 9462262B1 · Worley, III et al. · 2016 [cited by applicant]
US 9581819B1 · Boggs et al. · 2017 [cited by applicant]
US 9652031B1 · Savastinuk et al. · 2017 [cited by applicant]
US 9995936B1 · Macannuco et al. · 2018 [cited by applicant]
US 9996535B1 · Skidmore et al. · 2018 [cited by applicant]
US 10168782B1 · Tchon et al. · 2019 [cited by applicant]
US 10186168B2 · Gobert et al. · 2019 [cited by applicant]
US 10205643B2 · Fletcher et al. · 2019 [cited by applicant]
US 10311645B1 · Ravindran et al. · 2019 [cited by applicant]
US 10353483B2 · Kramer et al. · 2019 [cited by applicant]
US 10417704B2 · Searson et al. · 2019 [cited by applicant]
US 10467234B2 · Nerurkar et al. · 2019 [cited by applicant]
US 10467980B2 · Watson et al. · 2019 [cited by applicant]
US 10529140B1 · Ravindran et al. · 2020 [cited by applicant]
US 10541054B2 · Zalis et al. · 2020 [cited by applicant]
US 10621164B1 · Kain · 2020 [cited by applicant]
US 10664133B1 · Rowny et al. · 2020 [cited by applicant]
US 10702773B2 · Davis · 2020 [cited by applicant]
US 10768605B2 · Dalal et al. · 2020 [cited by applicant]
US 10824238B2 · Kramer et al. · 2020 [cited by applicant]
US 10831286B1 · Pepose et al. · 2020 [cited by applicant]
US 10831733B2 · Gomez et al. · 2020 [cited by applicant]
US 10846603B2 · Yamagami et al. · 2020 [cited by applicant]
US 10884525B1 · Vonsik et al. · 2021 [cited by applicant]
US 10885719B1 · Ravindran et al. · 2021 [cited by applicant]
US 11079888B1 · Gray et al. · 2021 [cited by applicant]
US 11210968B2 · Clevenger et al. · 2021 [cited by applicant]
US 11262885B1 · Burckel · 2022 [cited by applicant]
US 11295511B1 · Yosifov et al. · 2022 [cited by applicant]
US 11615712B2 · Park et al. · 2023 [cited by applicant]
US 11630633B1 · Macdougall · 2023 [cited by applicant]
US 12333065B1 · Ravindran · 2025 [cited by applicant]
US 20010025304A1 · Keith, Jr. · 2001 [cited by applicant]
US 20020091687A1 · Eglington · 2002 [cited by applicant]
US 20020107959A1 · Shteyn · 2002 [cited by applicant]
US 20020174088A1 · Liu et al. · 2002 [cited by applicant]
US 20030140018A1 · Epstein et al. · 2003 [cited by applicant]
US 20040109009A1 · Yonezawa et al. · 2004 [cited by applicant]
US 20040172347A1 · Barthel · 2004 [cited by applicant]
US 20040197750A1 · Donaher et al. · 2004 [cited by applicant]
US 20050024388A1 · Takemoto · 2005 [cited by applicant]
US 20050054381A1 · Lee et al. · 2005 [cited by applicant]
US 20050118996A1 · Lee et al. · 2005 [cited by applicant]
US 20050143138A1 · Lee et al. · 2005 [cited by applicant]
US 20050156932A1 · Vienneau et al. · 2005 [cited by applicant]
US 20060235548A1 · Gaudette · 2006 [cited by applicant]
US 20070214136A1 · MacLennan et al. · 2007 [cited by applicant]
US 20080235164A1 · Tian et al. · 2008 [cited by applicant]
US 20080280276A1 · Raber et al. · 2008 [cited by applicant]
US 20090031239A1 · Coleran et al. · 2009 [cited by applicant]
US 20090271715A1 · Tumuluri · 2009 [cited by applicant]
US 20100074141A1 · Nguyen · 2010 [cited by applicant]
US 20100262598A1 · Koyama et al. · 2010 [cited by applicant]
US 20100278384A1 · Shotton et al. · 2010 [cited by applicant]
US 20110009241A1 · Lane et al. · 2011 [cited by applicant]
US 20110210915A1 · Shotton et al. · 2011 [cited by applicant]
US 20120142415A1 · Lindsay · 2012 [cited by applicant]
US 20120172126A1 · Padovani et al. · 2012 [cited by applicant]
US 20120212405A1 · Newhouse et al. · 2012 [cited by applicant]
US 20120218306A1 · Mcardle et al. · 2012 [cited by applicant]
US 20120236029A1 · Newhouse et al. · 2012 [cited by applicant]
US 20120242656A1 · Mcardle et al. · 2012 [cited by applicant]
US 20120242798A1 · Mcardle et al. · 2012 [cited by applicant]
US 20120246223A1 · Newhouse et al. · 2012 [cited by applicant]
US 20120323824A1 · Gansner · 2012 [cited by applicant]
US 20130117280A1 · Donaldson et al. · 2013 [cited by applicant]
US 20130127980A1 · Haddick et al. · 2013 [cited by applicant]
US 20130169514A1 · Edwards et al. · 2013 [cited by applicant]
US 20130222273A1 · Tan · 2013 [cited by applicant]
US 20130251126A1 · Hollander et al. · 2013 [cited by applicant]
US 20140002493A1 · Mitchell et al. · 2014 [cited by applicant]
US 20140028712A1 · Keating et al. · 2014 [cited by applicant]
US 20140071165A1 · Tuchschmid et al. · 2014 [cited by applicant]
US 20140139551A1 · McCulloch et al. · 2014 [cited by applicant]
US 20140143676A1 · Tan · 2014 [cited by applicant]
US 20140143687A1 · Tan et al. · 2014 [cited by applicant]
US 20140143735A1 · Dahn · 2014 [cited by applicant]
US 20140149177A1 · Frank et al. · 2014 [cited by applicant]
US 20140176603A1 · Kumar et al. · 2014 [cited by applicant]
US 20140204118A1 · Berry et al. · 2014 [cited by applicant]
US 20140223462A1 · Aimone et al. · 2014 [cited by applicant]
US 20140240313A1 · Varga · 2014 [cited by applicant]
US 20140310595A1 · Acharya et al. · 2014 [cited by applicant]
US 20140335497A1 · Gal et al. · 2014 [cited by applicant]
US 20140342333A1 · Knoche et al. · 2014 [cited by applicant]
US 20150019569A1 · Parker et al. · 2015 [cited by applicant]
US 20150081685A1 · Ashenfelter et al. · 2015 [cited by applicant]
US 20150091780A1 · Lyren · 2015 [cited by applicant]
US 20150097860A1 · Alaniz et al. · 2015 [cited by applicant]
US 20150097863A1 · Alaniz et al. · 2015 [cited by applicant]
US 20150097864A1 · Alaniz et al. · 2015 [cited by applicant]
US 20150243085A1 · Newhouse et al. · 2015 [cited by applicant]
US 20150260474A1 · Rublowsky et al. · 2015 [cited by applicant]
US 20150278695A1 · Shah · 2015 [cited by applicant]
US 20150310444A1 · Chen et al. · 2015 [cited by applicant]
US 20160019808A1 · Chavez et al. · 2016 [cited by applicant]
US 20160063209A1 · Malaviya · 2016 [cited by applicant]
US 20160077547A1 · Aimone et al. · 2016 [cited by applicant]
US 20160081597A1 · Bhavaraju et al. · 2016 [cited by applicant]
US 20160127552A1 · Sharma et al. · 2016 [cited by applicant]
US 20160148417A1 · Kim et al. · 2016 [cited by applicant]
US 20160196765A1 · Stauch et al. · 2016 [cited by applicant]
US 20160249989A1 · Devam et al. · 2016 [cited by applicant]
US 20160253843A1 · Lee · 2016 [cited by applicant]
US 20160269631A1 · Jiang et al. · 2016 [cited by applicant]
US 20160291922A1 · Montgomerie et al. · 2016 [cited by applicant]
US 20160321414A1 · Salganicoff et al. · 2016 [cited by applicant]
US 20160349838A1 · Solomon et al. · 2016 [cited by applicant]
US 20160350595A1 · Solomin et al. · 2016 [cited by applicant]
US 20160367202A1 · Carter et al. · 2016 [cited by applicant]
US 20160371051A1 · Rowe et al. · 2016 [cited by applicant]
US 20170007351A1 · Yu · 2017 [cited by applicant]
US 20170048033A1 · Porat · 2017 [cited by applicant]
US 20170059871A1 · Hashiba et al. · 2017 [cited by applicant]
US 20170060831A1 · Smythe et al. · 2017 [cited by applicant]
US 20170076491A1 · Jiang et al. · 2017 [cited by applicant]
US 20170193551A1 · Santi · 2017 [cited by applicant]
US 20170212651A1 · Courvoisier et al. · 2017 [cited by applicant]
US 20170227754A1 · Huang · 2017 [cited by applicant]
US 20170293705A1 · Van Der Velden et al. · 2017 [cited by applicant]
US 20170329856A1 · Jiang et al. · 2017 [cited by applicant]
US 20170332303A1 · Sunay et al. · 2017 [cited by applicant]
US 20170365101A1 · Samec et al. · 2017 [cited by applicant]
US 20180059812A1 · Inomata et al. · 2018 [cited by applicant]
US 20180062931A1 · Joshi et al. · 2018 [cited by applicant]
US 20180090029A1 · Fisher et al. · 2018 [cited by applicant]
US 20180098813A1 · Nesichi et al. · 2018 [cited by applicant]
US 20180101391A1 · Cunha et al. · 2018 [cited by applicant]
US 20180121622A1 · Armstrong et al. · 2018 [cited by applicant]
US 20180137771A1 · Wahidy et al. · 2018 [cited by applicant]
US 20180173323A1 · Harvey et al. · 2018 [cited by applicant]
US 20180174256A1 · Franz et al. · 2018 [cited by applicant]
US 20180189568A1 · Powderly et al. · 2018 [cited by applicant]
US 20180193589A1 · McLaughlin et al. · 2018 [cited by applicant]
US 20180224928A1 · Ross et al. · 2018 [cited by applicant]
US 20180247023A1 · Divine et al. · 2018 [cited by applicant]
US 20180254097A1 · Gani et al. · 2018 [cited by applicant]
US 20180293802A1 · Hendricks et al. · 2018 [cited by applicant]
US 20180307303A1 · Powderly et al. · 2018 [cited by applicant]
US 20180308377A1 · Pena-Rios et al. · 2018 [cited by applicant]
US 20180314322A1 · Tseng · 2018 [cited by applicant]
US 20180357915A1 · Harlow et al. · 2018 [cited by applicant]
US 20180374268A1 · Niles · 2018 [cited by applicant]
US 20190019092A1 · Baughman et al. · 2019 [cited by applicant]
US 20190065027A1 · Hauenstein et al. · 2019 [cited by applicant]
US 20190113973A1 · Coleman et al. · 2019 [cited by applicant]
US 20190130781A1 · Nissen et al. · 2019 [cited by applicant]
US 20190139426A1 · Kesavadas et al. · 2019 [cited by applicant]
US 20190188450A1 · Spivack et al. · 2019 [cited by applicant]
US 20190188876A1 · Song et al. · 2019 [cited by applicant]
US 20190196663A1 · Monastyrshyn et al. · 2019 [cited by applicant]
US 20190197141A1 · Gomez et al. · 2019 [cited by applicant]
US 20190197785A1 · Tate-Gans et al. · 2019 [cited by applicant]
US 20190228533A1 · Giurgica-Tiron et al. · 2019 [cited by applicant]
US 20190232500A1 · Bennett et al. · 2019 [cited by applicant]
US 20190251965A1 · Dharne · 2019 [cited by applicant]
US 20190251966A1 · Dharne · 2019 [cited by applicant]
US 20190255350A1 · Malchano et al. · 2019 [cited by applicant]
US 20190279746A1 · Kohle et al. · 2019 [cited by applicant]
US 20190282324A1 · Freeman et al. · 2019 [cited by applicant]
US 20190285867A1 · Huang · 2019 [cited by applicant]
US 20190304188A1 · Bridgeman et al. · 2019 [cited by applicant]
US 20190318421A1 · Lyonnet et al. · 2019 [cited by applicant]
US 20190362312A1 · Platt et al. · 2019 [cited by applicant]
US 20190362557A1 · Lacey et al. · 2019 [cited by applicant]
US 20190362641A1 · Sukhwani et al. · 2019 [cited by applicant]
US 20190369838A1 · Josephson et al. · 2019 [cited by applicant]
US 20190380792A1 · Poltaretskyi et al. · 2019 [cited by applicant]
US 20200026922A1 · Pekelny et al. · 2020 [cited by applicant]
US 20200050342A1 · Lee · 2020 [cited by applicant]
US 20200051448A1 · Welch et al. · 2020 [cited by applicant]
US 20200065396A1 · Ozcaglar et al. · 2020 [cited by applicant]
US 20200066049A1 · Sun et al. · 2020 [cited by applicant]
US 20200073482A1 · Levesque · 2020 [cited by applicant]
US 20200090542A1 · Clevenger · 2020 [cited by examiner]
US 20200092094A1 · Resch et al. · 2020 [cited by applicant]
US 20200111255A1 · Brodsky et al. · 2020 [cited by applicant]
US 20200111376A1 · Breeding et al. · 2020 [cited by applicant]
US 20200134780A1 · Chapiro et al. · 2020 [cited by applicant]
US 20200213117A1 · Resch et al. · 2020 [cited by applicant]
US 20200265754A1 · Buras et al. · 2020 [cited by applicant]
US 20200286294A1 · Musara · 2020 [cited by applicant]
US 20200289937A1 · Osman · 2020 [cited by applicant]
US 20200294408A1 · Olivieri et al. · 2020 [cited by applicant]
US 20200306643A1 · Borovikov et al. · 2020 [cited by applicant]
US 20200319856A1 · Loria · 2020 [cited by applicant]
US 20200320794A1 · Huang et al. · 2020 [cited by applicant]
US 20200327378A1 · Smith et al. · 2020 [cited by applicant]
US 20200327816A1 · Verma et al. · 2020 [cited by applicant]
US 20200334463A1 · Shapira · 2020 [cited by applicant]
US 20200337625A1 · Aimone et al. · 2020 [cited by applicant]
US 20200356897A1 · Diggle et al. · 2020 [cited by applicant]
US 20200388077A1 · Ninan et al. · 2020 [cited by applicant]
US 20200411199A1 · Shrager et al. · 2020 [cited by applicant]
US 20210011606A1 · Brown, IV et al. · 2021 [cited by applicant]
US 20210029803A1 · Olaleye et al. · 2021 [cited by applicant]
US 20210065573A1 · Rakshit et al. · 2021 [cited by applicant]
US 20210069574A1 · O'Dowd et al. · 2021 [cited by applicant]
US 20210089117A1 · Bodolec et al. · 2021 [cited by applicant]
US 20210090449A1 · Smith et al. · 2021 [cited by applicant]
US 20210097776A1 · Faulkner et al. · 2021 [cited by applicant]
US 20210133509A1 · Wall et al. · 2021 [cited by applicant]
US 20210191600A1 · Lemay et al. · 2021 [cited by applicant]
US 20210240279A1 · Harviainen et al. · 2021 [cited by applicant]
US 20210255730A1 · Gray et al. · 2021 [cited by applicant]
US 20210256874A1 · Harel et al. · 2021 [cited by applicant]
US 20210335490A1 · Arroyo Camejo et al. · 2021 [cited by applicant]
US 20210337341A1 · Sakuma · 2021 [cited by applicant]
US 20210346805A1 · Daniali · 2021 [cited by applicant]
US 20210369080A1 · Takahashi et al. · 2021 [cited by applicant]
US 20210369394A1 · Braido et al. · 2021 [cited by applicant]
US 20210383912A1 · Jackson et al. · 2021 [cited by applicant]
US 20210405738A1 · Bodolec et al. · 2021 [cited by applicant]
US 20220124143A1 · Rafkind et al. · 2022 [cited by applicant]
US 20220172633A1 · Jha et al. · 2022 [cited by applicant]
US 20220179552A1 · Burckel · 2022 [cited by applicant]
US 20220208016A1 · Le Chevalier · 2022 [cited by applicant]
US 20220229535A1 · Evangelista et al. · 2022 [cited by applicant]
US 20220255974A1 · Berliner et al. · 2022 [cited by applicant]
US 20220255995A1 · Berliner et al. · 2022 [cited by applicant]
US 20220304604A1 · Costea · 2022 [cited by applicant]
US 20220317830A1 · Skuratowicz et al. · 2022 [cited by applicant]
US 20220343590A1 · Jutan et al. · 2022 [cited by applicant]
US 20220343591A1 · Jutan et al. · 2022 [cited by applicant]
US 20230007085A1 · Berliner et al. · 2023 [cited by applicant]
US 20230100610A1 · Pastrana Vicente et al. · 2023 [cited by applicant]
US 20230105621A1 · Karri et al. · 2023 [cited by applicant]
US 20230129708A1 · Stone et al. · 2023 [cited by applicant]
US 20230164202A1 · Kumar Agrawal et al. · 2023 [cited by applicant]
US 20240081706A1 · Alailima · 2024 [cited by examiner]
Co-pending U.S. Appl. No. 16/594,248, inventors Ravindran; Vijay et al., filed Oct. 7, 2019. [cited by applicant]
Co-pending U.S. Appl. No. 17/110,383, inventors Ravindran; Vijay et al., filed Dec. 3, 2020. [cited by applicant]
Escobedo et al. Using Augmented Reality to Help Children with Autism Stay Focused. IEEE Pervasive Computing. Published: Feb. 28, 2014. pp. 38-46. [cited by applicant]
U.S. Appl. No. 15/782,216 Notice of Allowance dated Feb. 27, 2019. [cited by applicant]
U.S. Appl. No. 15/782,216 Office Action dated Feb. 8, 2019. [cited by applicant]
U.S. Appl. No. 15/782,216 Office Action dated Oct. 3, 2018. [cited by applicant]
U.S. Appl. No. 16/387,885 Notice of Allowance dated Sep. 25, 2019. [cited by applicant]
U.S. Appl. No. 16/594,248 Office Action dated Dec. 9, 2020. [cited by applicant]
U.S. Appl. No. 16/594,248 Office Action dated Feb. 5, 2024. [cited by applicant]
U.S. Appl. No. 16/594,248 Office Action dated Jan. 10, 2022. [cited by applicant]
U.S. Appl. No. 16/594,248 Office Action dated Jun. 12, 2023. [cited by applicant]
U.S. Appl. No. 16/594,248 Office Action dated Jun. 21, 2021. [cited by applicant]
U.S. Appl. No. 16/594,248 Office Action dated Oct. 7, 2022. [cited by applicant]
U.S. Appl. No. 16/697,816 Notice of Allowance dated Sep. 23, 2020. [cited by applicant]
U.S. Appl. No. 16/697,816 Office Action dated May 26, 2020. [cited by applicant]
U.S. Appl. No. 18/795,031 Notice of Allowance dated Feb. 18, 2025. [cited by applicant]
U.S. Appl. No. 18/795,031 Office Action dated Sep. 27, 2024. [cited by applicant]